HFS
XBI icon

HL Financial Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

HL Financial Services’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$7.03M Buy
77,640
+5,834
+8% +$496K 0.11% 118
2018
Q4 		$5.15M Buy
71,806
+7,483
+12% +$603K 0.09% 145
2018
Q3 		$6.17M Buy
64,323
+53,476
+493% +$5.18M 0.1% 129
2018
Q2 		$1.03M Sell
10,847
-350
-3% -$32.2K 0.02% 362
2018
Q1 		$982K Sell
11,197
-311
-3% -$28.4K 0.02% 364
2017
Q4 		$977K Sell
11,508
-791
-6% -$66.3K 0.02% 316
2017
Q3 		$1.06M Sell
12,299
-7,938
-39% -$636K 0.02% 343
2017
Q2 		$1.56M Buy
20,237
+1,886
+10% +$134K 0.03% 272
2017
Q1 		$1.27M Buy
18,351
+6,680
+57% +$449K 0.03% 299
2016
Q4 		$691K Buy
11,671
+780
+7% +$48.1K 0.01% 390
2016
Q3 		$722K Buy
10,891
+1,710
+19% +$106K 0.02% 367
2016
Q2 		$497K Buy
9,181
+668
+8% +$36.6K 0.01% 428
2016
Q1 		$440K Sell
8,513
-375
-4% -$19.5K 0.01% 452
2015
Q4 		$624K Sell
8,888
-125
-1% -$8.53K 0.02% 393
2015
Q3 		$561K Sell
9,013
-152
-2% -$12K 0.02% 393
2015
Q2 		$771K Sell
9,165
-255
-3% -$19.8K 0.02% 367
2015
Q1 		$708K Hold
9,420
– – 0.02% 376
2014
Q4 		$585K Hold
9,420
– – 0.02% 391
2014
Q3 		$490K Hold
9,420
– – 0.01% 420
2014
Q2 		$484K Sell
9,420
-1,083
-10% -$48.8K 0.01% 425
2014
Q1 		$499K Sell
10,503
-75
-0.7% -$3.84K 0.02% 399
2013
Q4 		$459K Sell
10,578
-315
-3% -$13K 0.01% 409
2013
Q3 		$469K Buy
10,893
+273
+3% +$11.1K 0.02% 370
2013
Q2 		$369K Buy
+10,620
New +$373K 0.01% 393

Other funds holding XBI

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

HL Financial Services's XBI Position: Q1 2019 in Review

HL Financial Services increased its State Street SPDR S&P Biotech ETF (XBI) stake by 8.1% in Q1 2019, buying an estimated $496K and bringing the position to 77,640 shares worth $7.03M. The position accounts for 0.11% of the portfolio, ranked #118.

HL Financial Services first reported a position in XBI in Q2 2013 and has held it in 24 quarters since. 451 funds tracked by Wall St. Rank hold XBI as of Q1 2019.

  • HL Financial Services held 77,640 shares of State Street SPDR S&P Biotech ETF worth $7.03M as of Q1 2019.
  • HL Financial Services bought 5,834 State Street SPDR S&P Biotech ETF shares in Q1 2019, an estimated $496K.
  • State Street SPDR S&P Biotech ETF made up 0.11% of HL Financial Services's portfolio in Q1 2019, its #118 holding.
  • HL Financial Services first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 24 quarters since.
  • 451 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2019.

Based on HL Financial Services's 13F filing for Q1 2019, filed 1 May 2019.